Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

High-Flow Nasal Cannulae. The Quest for the Holy Grail in the Critical Respiratory Patient?

Masclans JR, Dot I, Pérez-Teran P.

Arch Bronconeumol. 2018 Sep 5. pii: S0300-2896(18)30305-3. doi: 10.1016/j.arbres.2018.07.015. [Epub ahead of print] English, Spanish. No abstract available.

2.

Noninvasive ventilation for respiratory failure: a note of caution in selected patients.

Macharete C, Ventura L, Rubio O, Catalan I, Cano S, Alcoverro JM, Subira C, Masclans J, Rognoni G, Fernandez R.

Intensive Care Med. 2018 Jun 22. doi: 10.1007/s00134-018-5275-9. [Epub ahead of print] No abstract available.

PMID:
29934923
3.

Soluble Suppression of Tumorigenicity-2 Predicts Hospital Mortality in Burn Patients: An Observational Prospective Cohort Pilot Study.

Ruiz-Castilla M, Bosacoma P, Dos Santos B, Baena J, Guilabert P, Marin-Corral J, Masclans JR, Roca O, Barret JP.

Shock. 2018 Apr 10. doi: 10.1097/SHK.0000000000001155. [Epub ahead of print]

PMID:
29642231
4.

Patients with influenza A (H1N1)pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC.

Marin-Corral J, Climent C, Muñoz R, Samper M, Dot I, Vilà C, Masclans JR, Rodriguez A, Martin-Loeches I, Álvarez-Lerma F; en representacion del Grupo de Trabajo H1N1 GETGAG SEMICYUC.

Med Intensiva. 2018 Mar 17. pii: S0210-5691(18)30048-2. doi: 10.1016/j.medin.2018.02.002. [Epub ahead of print] English, Spanish.

5.

A Before-and-After Study of the Effectiveness of an Antimicrobial Stewardship Program in Critical Care.

Álvarez-Lerma F, Grau S, Echeverría-Esnal D, Martínez-Alonso M, Gracia-Arnillas MP, Horcajada JP, Masclans JR.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01825-17. doi: 10.1128/AAC.01825-17. Print 2018 Apr.

PMID:
29339385
6.

Intensive care unit patients with lower respiratory tract nosocomial infections: the ENIRRIs project.

De Pascale G, Ranzani OT, Nseir S, Chastre J, Welte T, Antonelli M, Navalesi P, Garofalo E, Bruni A, Coelho LM, Skoczynski S, Longhini F, Taccone FS, Grimaldi D, Salzer HJF, Lange C, Froes F, Artigas A, Díaz E, Vallés J, Rodríguez A, Panigada M, Comellini V, Fasano L, Soave PM, Spinazzola G, Luyt CE, Alvarez-Lerma F, Marin J, Masclans JR, Chiumello D, Pezzi A, Schultz M, Mohamed H, Van Der Eerden M, Hoek RAS, Gommers DAMPJ, Pasquale MD, Civljak R, Kutleša M, Bassetti M, Dimopoulos G, Nava S, Rios F, Zampieri FG, Povoa P, Bos LD, Aliberti S, Torres A, Martín-Loeches I.

ERJ Open Res. 2017 Nov 17;3(4). pii: 00092-2017. doi: 10.1183/23120541.00092-2017. eCollection 2017 Oct.

7.

Severe vitamin D deficiency upon admission in critically ill patients is related to acute kidney injury and a poor prognosis.

Zapatero A, Dot I, Diaz Y, Gracia MP, Pérez-Terán P, Climent C, Masclans JR, Nolla J.

Med Intensiva. 2018 May;42(4):216-224. doi: 10.1016/j.medin.2017.07.004. Epub 2017 Aug 26. English, Spanish.

8.

Hypoxemic Patients With Bilateral Infiltrates Treated With High-Flow Nasal Cannula Present a Similar Pattern of Biomarkers of Inflammation and Injury to Acute Respiratory Distress Syndrome Patients.

García-de-Acilu M, Marin-Corral J, Vázquez A, Ruano L, Magret M, Ferrer R, Masclans JR, Roca O.

Crit Care Med. 2017 Nov;45(11):1845-1853. doi: 10.1097/CCM.0000000000002647.

PMID:
28806218
9.

Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection.

Rodríguez A, Ferri C, Martin-Loeches I, Díaz E, Masclans JR, Gordo F, Sole-Violán J, Bodí M, Avilés-Jurado FX, Trefler S, Magret M, Moreno G, Reyes LF, Marin-Corral J, Yebenes JC, Esteban A, Anzueto A, Aliberti S, Restrepo MI; Grupo Español de Trabajo Gripe A Grave (GETGAG)/Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) Working Group; 2009-2015 H1N1 SEMICYUC Working Group investigators.

Respir Care. 2017 Oct;62(10):1307-1315. doi: 10.4187/respcare.05481. Epub 2017 Jul 11.

PMID:
28698265
10.

High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial.

Fernandez R, Subira C, Frutos-Vivar F, Rialp G, Laborda C, Masclans JR, Lesmes A, Panadero L, Hernandez G.

Ann Intensive Care. 2017 Dec;7(1):47. doi: 10.1186/s13613-017-0270-9. Epub 2017 May 2.

11.

Clinical significance and outcome of Aeromonas spp. infections among 204 adult patients.

Nolla-Salas J, Codina-Calero J, Vallés-Angulo S, Sitges-Serra A, Zapatero-Ferrándiz A, Climent MC, Gómez J, Masclans JR.

Eur J Clin Microbiol Infect Dis. 2017 Aug;36(8):1393-1403. doi: 10.1007/s10096-017-2945-4. Epub 2017 Mar 3.

PMID:
28258303
12.

Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit.

Álvarez-Lerma F, Marín-Corral J, Vilà C, Masclans JR, Loeches IM, Barbadillo S, González de Molina FJ, Rodríguez A; H1N1 GETGAG/SEMICYUC Study Group.

J Hosp Infect. 2017 Feb;95(2):200-206. doi: 10.1016/j.jhin.2016.12.017. Epub 2016 Dec 30.

13.

Prospective validation of right ventricular role in primary graft dysfunction after lung transplantation.

Pérez-Terán P, Roca O, Rodríguez-Palomares J, Ruiz-Rodríguez JC, Zapatero A, Gea J, Serra J, Evangelista A, Masclans JR.

Eur Respir J. 2016 Dec;48(6):1732-1742. doi: 10.1183/13993003.02136-2015. Epub 2016 Oct 6.

14.

Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome.

Álvarez-Lerma F, Marín-Corral J, Vila C, Masclans JR, González de Molina FJ, Martín Loeches I, Barbadillo S, Rodríguez A; H1N1 GETGAG/SEMICYUC Study Group.

Crit Care. 2016 Oct 23;20(1):337.

15.

High Flow Therapy in Post-Lung Transplant Patients.

Masclans JR, Zapatero A, Sacanell J.

Arch Bronconeumol. 2017 Apr;53(4):182-183. doi: 10.1016/j.arbres.2016.07.014. Epub 2016 Aug 22. English, Spanish. No abstract available.

16.

Diaphragm Dysfunction in Mechanically Ventilated Patients.

Dot I, Pérez-Teran P, Samper MA, Masclans JR.

Arch Bronconeumol. 2017 Mar;53(3):150-156. doi: 10.1016/j.arbres.2016.07.008. Epub 2016 Aug 21. Review. English, Spanish.

17.

Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.

Roca O, Messika J, Caralt B, García-de-Acilu M, Sztrymf B, Ricard JD, Masclans JR.

J Crit Care. 2016 Oct;35:200-5. doi: 10.1016/j.jcrc.2016.05.022. Epub 2016 May 31.

PMID:
27481760
18.

Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure.

Roca O, Hernández G, Díaz-Lobato S, Carratalá JM, Gutiérrez RM, Masclans JR; Spanish Multidisciplinary Group of High Flow Supportive Therapy in Adults (HiSpaFlow).

Crit Care. 2016 Apr 28;20(1):109. doi: 10.1186/s13054-016-1263-z. Review.

19.

RECENT ADVANCES IN BIOMARKERS IN SEVERE BURNS.

Ruiz-Castilla M, Roca O, Masclans JR, Barret JP.

Shock. 2016 Feb;45(2):117-25. doi: 10.1097/SHK.0000000000000497. Review.

PMID:
26771933
20.

The role of high flow oxygen therapy in acute respiratory failure.

Masclans JR, Pérez-Terán P, Roca O.

Med Intensiva. 2015 Nov;39(8):505-15. doi: 10.1016/j.medin.2015.05.009. Epub 2015 Oct 1. Review. English, Spanish.

Supplemental Content

Loading ...
Support Center